T.H. v. Novartis Pharmaceutical Corp., 4 Cal. 5th 145 (2017)

A lower court ruled that: consumers injured by generic drugs can sue brand-name manufacturers of that drug for misrepresentations in the drug’s warning label; and the defense counsel had waived the attorney-client privilege when they failed to promptly ask plaintiffs to return a privileged document inadvertently sent. The court of appeal affirmed the lower court’s ruling.